| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/08/2001 | WO2001028574A3 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
| 11/08/2001 | WO2001026680A3 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 11/08/2001 | WO2001025403A3 Bio-artificial substrate for the production of animal and, in particular, human tissues and organs |
| 11/08/2001 | WO2001023414A3 Immunologically significant herpes simplex virus antigens |
| 11/08/2001 | WO2001018035A3 Muc-1 derived peptides |
| 11/08/2001 | US20010039667 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease |
| 11/08/2001 | US20010039050 Serum-free cell growth medium |
| 11/08/2001 | US20010039049 Inducing multipotent neural stem cells to proliferate in the presence of the title hormone to produce neuronal progenitor cells and allowing them to differentiate into neurons Parkinson's and Alzheimer diseases; transplantation |
| 11/08/2001 | US20010039046 Genetically engineered adenovirus comprising a genome whose E1 region is deactivated, whose organization is modified and the recombination of which with the genome of the producing line leads to the new viral vectors; gene therapy |
| 11/08/2001 | US20010039038 Novel glucosaminidase |
| 11/08/2001 | US20010039027 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 11/08/2001 | US20010038847 Subjecting animal pericardium to multiple steps of freezing and thawing in a salt solution, and incubating in a solution of ammonia and ethyl alcohol to produce a biological material for use in ophthalmology such as antiglaucoma drainage tube |
| 11/08/2001 | US20010038845 Parenterally administering large liposomes comprised of phospholipids free of sterol which pick-up cholesterol druing the treatment period; liposomes too large to penetrate fenestrations of endothelial lining hepatic sinusoids |
| 11/08/2001 | US20010038837 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart |
| 11/08/2001 | US20010038836 Administering a mammalian stem cells of myeloid origin into a nervous system of the mammal, migrating these cells from injection site to prefered site in a nervous system, engrafting above cells into nervous system of the mammal |
| 11/08/2001 | US20010038835 Culturing selected cells, plating the cultured cells onto an overlying and an underlying membranes and moving the overlying membrane across the underlaying membrane to stretch and split into two populations connected by elongated cells |
| 11/08/2001 | US20010038834 A therapeutic agent, comprising a bone marrow cell which has been transfected with DNA operably connected to a promoter, which DNA encodes the expression of antitumer agent when introduced into a mammal, homes to bone marrow of the mammal |
| 11/08/2001 | CA2605803A1 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 11/08/2001 | CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof |
| 11/08/2001 | CA2407881A1 Vectors for ocular transduction and use thereof for genetic therapy |
| 11/08/2001 | CA2407724A1 Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal |
| 11/08/2001 | CA2407700A1 Compositions and methods for inducing activation of dendritic cells |
| 11/08/2001 | CA2407696A1 Isolation of mesenchymal stem cells and use thereof |
| 11/08/2001 | CA2407614A1 Dried microorganism cell product by spray-drying |
| 11/08/2001 | CA2407136A1 Treatment of conditions of the central nervous system using mycobacteria |
| 11/08/2001 | CA2406755A1 A gene therapy system and method using alpha-msh and its derivatives |
| 11/08/2001 | CA2406746A1 Methods and compositions for impairing multiplication of hiv-1 |
| 11/08/2001 | CA2406743A1 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 11/07/2001 | EP1152243A1 DIagnosis of Sjögren's syndrome, systemic lupus erythematosis, and scleroderma via detection of anti-retroviral antibodies |
| 11/07/2001 | EP1151756A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 11/07/2001 | EP1151754A1 Use of a equine milk fraction for the inhibition of interleukin-1 production |
| 11/07/2001 | EP1151124A1 Gene repair involving in vivo excision of targeting dna |
| 11/07/2001 | EP1151123A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
| 11/07/2001 | EP1151091A1 Improved helper dependent vector system for gene therapy |
| 11/07/2001 | EP1151082A1 Sebocytes, sebocyte cell lines and applications thereof |
| 11/07/2001 | EP1151080A2 Anti-transforming growth factor beta (tgf- beta) treated stem cell composition and method |
| 11/07/2001 | EP1151067A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil |
| 11/07/2001 | EP1151004A1 Method for producing il-1ra, a therapeutically active protein from body fluids |
| 11/07/2001 | EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 11/07/2001 | EP1150939A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer |
| 11/07/2001 | EP1150728A1 Methods and compositions for use in perfusion applications |
| 11/07/2001 | EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules |
| 11/07/2001 | EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 11/07/2001 | EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 11/07/2001 | EP1150702A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
| 11/07/2001 | EP1150698A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 11/07/2001 | EP1150696A2 Treatment of tumors with genetically engineered herpes virus |
| 11/07/2001 | EP1150694A1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same |
| 11/07/2001 | EP1150693A1 Immunogenic compositions for use as vaccines |
| 11/07/2001 | EP1150577A1 Improved microbial preparations |
| 11/07/2001 | EP1150570A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 11/07/2001 | EP1003532B1 Lactobacilli to increase absorption of minerals by intestinal cells |
| 11/07/2001 | EP0980205A4 Method of treating malignancies |
| 11/07/2001 | EP0918469B1 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 11/07/2001 | EP0835108B1 Use of lamellarin-class alkaloids in methods of treatment |
| 11/07/2001 | EP0783693B1 In vitro models of cns function and dysfunction |
| 11/07/2001 | EP0769917B1 Nervonic acid compositions |
| 11/07/2001 | EP0726772B1 A method for sensitization of cancer cells for killer cell mediated lysis |
| 11/07/2001 | EP0689596B1 Stimulation of immune response by viral protein |
| 11/07/2001 | CN1321246A Method of bleaching blood samples, diagnostic method and diagnostic kit using same |
| 11/07/2001 | CN1321199A Cell lines for propagation of mutated herpes viruses |
| 11/07/2001 | CN1321167A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of HLA |
| 11/07/2001 | CN1321093A Method to enhance and confine expression of genes |
| 11/07/2001 | CN1320445A Chinese-medicinal pill for treating rheumatoid arthritis |
| 11/07/2001 | CN1320442A Medicine for treating rheumatisms |
| 11/07/2001 | CN1320433A Process for preparing powdered medicine to treat rhinitis and nasosinusitis |
| 11/07/2001 | CN1320421A Freeze dried preparation of bacteriophagic Bdellovibrio and its preparing process |
| 11/07/2001 | CN1074295C 'Sanfengkangai' capsule for treating lung cancer and its preparing process |
| 11/07/2001 | CN1074294C Method for producing medicinal liquor for treating rheumatism |
| 11/07/2001 | CN1074292C Cancer treating medicine capsule |
| 11/07/2001 | CN1074291C Medicinal ox horn |
| 11/07/2001 | CN1074290C Medicine for treating facial paralysis and its preparing method |
| 11/07/2001 | CN1074287C Medicine for treatment of neurasthenia and its preparation process |
| 11/07/2001 | CN1074280C Micromolar placental active matter composition, its preparing process and application in cosmetics |
| 11/06/2001 | US6313369 Wound healing agents |
| 11/06/2001 | US6313270 DbpB |
| 11/06/2001 | US6313167 Administering unsaturated fatty acid or a derivative thereof as an active ingredient for preventing athletic anemia |
| 11/06/2001 | US6313128 Can be used as lypolysis/lypogenesis regulators in the skin without, interferring with the skin's natural functions; for therapy of saborrhea and acne |
| 11/06/2001 | US6312952 In vitro cell culture device including cartilage and methods of using the same |
| 11/06/2001 | US6312946 Viable contaminant particle free adenoviruses, their prepartion and use |
| 11/06/2001 | US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases |
| 11/06/2001 | US6312699 Genetic engineering of adenoviral fiber protein with caboxy end group |
| 11/06/2001 | US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells |
| 11/06/2001 | US6312685 Red blood cells covalently bound with two different polyethylene glycol derivatives |
| 11/06/2001 | US6312684 Antitumor agents |
| 11/06/2001 | US6312683 Equine infectious anemia virus vectors |
| 11/01/2001 | WO2001081577A2 Dna encoding the prost 03 polypeptide |
| 11/01/2001 | WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 11/01/2001 | WO2001081552A1 Patterned substrates and methods for nerve regeneration |
| 11/01/2001 | WO2001081551A2 Retinal pigment epithelial cell lines with extended life-span and their applications |
| 11/01/2001 | WO2001081549A2 Hepatocyte lineage cells derived from pluripotent stem cells |
| 11/01/2001 | WO2001080873A2 Thrombopoietin receptor modulating peptide |
| 11/01/2001 | WO2001080867A1 Method for improving the quality of sperm for artificial insemination of animals |
| 11/01/2001 | WO2001080866A1 Immunostimulatory pharmaceutical composition and its use protocol |
| 11/01/2001 | WO2001080865A2 Joint repair using mesenchymal stem cells |
| 11/01/2001 | WO2001080864A2 Chemical modification of mammalian urine and blood |
| 11/01/2001 | WO2001080760A1 Method for expansion of epithelial stem cells |
| 11/01/2001 | WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 11/01/2001 | WO2001043754A3 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases |
| 11/01/2001 | WO2001042263A3 Oligosaccharide mixture |